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Purpose: To evaluate and compare the intraaneurysmal pressure (IAP) after exclusion 
using two different endovascular g afts. 
Methods: Eight mongrel dogs had a 3 x 3 cm polytetrafluoroethylene (PTFE) aneurysm 
sewn as an interposition graft of the infrarenal aorta. A pressure transducer implanted 
into the aneurysm wall permitted continuous electronic IAP monitoring. Four aneurysms 
were excluded with a transluminally placed endovascular g aft made of a PTFE graft and 
two Palmaz stents (PTFE-EG), three were excluded with a tantalmn-Dacron e dovascu- 
lax graft (TD-EG), and one was surgically treated with a standard PTFE graft (PTFE- 
Surg). The dogs were observed for 18 to 50 days (mean, 37.5 days) and were evaluated 
after surgery with duplex and spiral computed tomographic scans. 
Results: All grafts successfully excluded the aneurysms without perigraft channels or leaks 
as docttmented by arteriogram and duplex and computed tomographic scans. The mean 
IAPs after repair with all PTFE-EGs were significantly lower (p < 0.001) than the mean 
systemic pressures. In addition, the mean IAP reduction was significantly greater (p < 
0.005) in the PTFE-EG group than in the TD-EG group. 
Conclusions: Aneurysm exclusion with PTFE-EG significantly lowered IAP, did so signif- 
icantly better than the TD-EG, and approached the IAP reduction obtained by standard 
repair. Such pressure reduction is necessary for effective protection against aneurysm 
rupture. (J Vase Surg 1997;26:222-30.) 
The most significant and devastating complica- 
tion of abdominal aortic aneurysms (AAAs) is rup- 
ture, and it results in more than 15,000 deaths each 
year in the United States? The only effective treat- 
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ment for AAAs is open surgical repair. Recent series 
have reported excellent results for elective aneurysm 
repair, with mortality rates lower than 5%. 2 4 This figure 
can be as high as 10% in some commtmity-based set- 
tings, sgreater than 20% for patients with severe comor- 
bid medical conditions, 6 and even higher for patients 
who require emergent repair for ruptured AAAs. 2-4,7 
Endovascular grafts have the potential of  success- 
fully treating patients with A2AAs with decreased 
morbidity rates, decreased mortality rates, and re- 
duced treatment costs. In addition, they may be used 
for the treatment of high-risk patients who cannot 
undergo standard surgical repair. However, the ef- 
fectiveness of successful endovascular graft repair in 
reducing the pressure within the excluded aneurys- 
mal sac has not been clearly demonstrated. 
A new animal model developed by our group 8 
that allows the chronic ambulatory monitoring of 
intraaneurysrnal pressure (IAP) was used to evaluate 
and compare the effectiveness of aneurysm exclusion 
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after standard surgical repair and endovascular repair 
using two different devices. 
MATERIALS AND METHODS 
The prosthetic aneurysm model that was previ- 
ously described by Faries et al. s was used. In sum- 
mary, the fusiform arterial aneurysms (3 × 3 cm) 
were created by balloon dilatation of an 8 mm poly- 
tetrafluoroethylene (PTFE) prosthetic graft (W. L. 
Gore and Associates, Flagstaff, Ariz.), preserving 5 
mm undilated segments proximally and distally for 
arterial anastomosis. An implantable silicon strain- 
gauge pressure transducer (P6.5-x6, Koningsberg 
Instruments, Pasadena, Calif.) was secured within 
the prosthetic aneurysm wall for continuous mea- 
surements of chronic IAP. 
Aneurysm implantation 
Eight female mongrel dogs weighing 25 to 30 
kgs underwent aneurysm implantation and repair. All 
dogs were cared for in accordance with the "Princi- 
ples of Laboratory Animal Care" (formulated by the 
National Society for Medical Research) and the 
Guide for the Care and Use of Laboratory Animals 
(NIH Publication No. 86-23, revised 1985). The 
dogs were initially anesthetized with intravenous so- 
dium pentobarbital (18 to 20 mg/kg),  intubated, 
and kept on a Harvard pump ventilator. The dog's 
blood pressure, heart rate, and urine output were 
closely monitored uring the procedure. 
Each dog was prepped and draped in standard 
sterile fashion, and 1 g cefazolin was administered 
intravenously before starting the procedure. A mid- 
line laparotomy incision was made. The infrarenal 
aorta was exposed from the renal arteries to the 
trifurcation. The aorta was inspected, and the 2 cm 
segment with the fewest branches was chosen for 
resection; these were ligated using 4-0 silk sutures 
(Ethicon, Inc., Summerville, N.J.). Heparin was 
given intravenously (751 U/kg),  and the aorta was 
clamped above and below the selected site. The 2 cm 
segment of aorta was resected, and the prosthetic 
aneurysm was anastomosed asan interposition graft 
using CV-7 PTFE sutures (W.L. Gore) (Fig. 1). The 
pressure transducer cable and skin appliance were 
passed through a separate fascial puncture into a 
subcutaneous pocket lateral to the midline incision 
and were secured to the fascia with a 2-0 silk suture 
(Ethicon). The abdominal fascia was then closed 
with a running 0 polypropylene suture (Ethicon), 
and the skin was closed with a running 4-0 polygly- 
colic acid subcuticular suture (Ethicon). The dog 
was turned onto her left side to access the lower 
Fig. 1. Intraoperative photograph of implanted PTFE 
aneurysm (A). Cable of pressure transducer xits to the 
right ofaneurysm (arrow). 
posterior neck. A 3 cm incision was made, and a 
subcutaneous tunneler was advanced from the neck 
to the subcutaneous pocket where the transducer 
cable was. The skin appliance at the end of the cable 
was tied to the tunneler and pulled through. The skin 
appliance was placed through aseparate stab incision 
and was secured to the skin with 2-0 polypropylene 
sutures (Ethicon). The original incision was closed 
with a 4-0 polyglycolic acid subcuticular suture 
(Ethicon). 
Standard aneurysm repair 
One dog underwent standard surgical aneurysm 
exclusion at the time of prosthetic aneurysm place- 
ment. A 6 mm PTFE graft (W.L. Gore) was inserted 
within the prosthetic aneurysm. The proximal and 
distal suture lines included the cuff of the prosthetic 
aneurysm and the previously inserted 6 mm graft. 
Subsequent blood flow was totally excluded from the 
aneurysm. The aneurysm cavity was filled until fully 
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Fig. 2. A, PTFE endovascular g aft was constructed by suturing one balloon expandable stent 
(PS) to the proximal end of a 4 mm PTFE graft dilated to 10 mm. After proximal stent 
deployment, a second stent (DS) was deployed to fix the distal end of the graft to the distal 
aorta. B, Tantalum-Dacron cokalit endovascular g aft has fenestrations ofapproximately 1 mm 
in width and 1.5 mm in length. 
distended with fresh blood by injecting 20 ml of 
blood withdrawn from the infrarenal aorta above the 
implanted aneurysm. 
Endovascular grafts 
The remaining seven dogs underwent endovascu- 
lar aneurysm exclusion 14 days after aneurysm im- 
plantation. Two different devices were used: a low- 
porosity PTFE endovascular g aft (PTFE-EG) and a 
high-porosity tantalum-Dacron endovascular graft 
(TD-EG;  Fig. 2). The PTFE-EG was 7.5 cm long 
and 10 mm in diameter. The graft was made by 
dilating a 4 mm PTFE graft (W.L. Gore) with a 10 
mm Blue Max balloon catheter (Mcditech, Inc.; 
Watertown, Mass.). A 1 cm balloon-expandable 
Palmaz stent (P 104, Johnson and Johnson Inter- 
ventional Systems, Warren, N.J.) was secured to 
the graft at one end using a CV-7 PTFE suture. 
The endovascular graft was mounted on a 10 mm 
X 6 cm Blue Max balloon catheter and backloaded 
into an l l F  introducer (Meditech). The TD-EG 
that was used was 6 cm long and 10 mm in diam- 
eter and was mounted on a 10 mm x 6 cm balloon 
catheter (Meditech). 
Endovascular aneurysm exclusion 
The dogs were anesthetized and monitored as 
previously described for aneurysm implantation. A
radiopaque ruler was placed behind the dog to facil- 
itate measuremcnts and accurate graft placement 
during the procedure. The neck was shaved, pre- 
pared, and drapcd in a sterile manner, and 1 g of 
cefazolin was administered. A midline neck incision 
was made, and the left carotid artery was isolated. 
Intravenous heparin (40 IU /kg)  was administered, 
and a 14F introducer catheter (UMI Corp., Ballston 
Spa, N.Y.) was advanced through a limited arteriot- 
omy. A 0.035-inch Amplatz Superstiff guidewire 
(Meditech) was then advanced into the infrarenal 
aorta under fluoroscopic ontrol, and a diagnostic 
angiographic atheter (Meditech) was introduced 
over the wire and advanced into the distal aorta. An 
angiogram was obtained using 20 ml Iohexol (Om- 
nipaque, NYCO Med Inc., DesPlaines, Ill.) to pre- 
cisely localize the aneurysm. An 0.018-inch guide- 
wire (Meditech) was advanced and the diagnostic 
catheter exchanged for a 5 MHz  intravascular ultra- 
sound (IVUS) catheter (Meditech). The aneurysm 
and the proximal and istal aorta were valuated. 
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The IVUS catheter was removed. The accuracy of 
the chronically implanted pressure transducer was 
confirmed by comparing the IAP with the pressure 
measurements obtained from a forelimb sphygmo- 
manometer and an intravascular manometer cath- 
eter (Miller Instruments, Houston, Tex.). 
The endovascular g afts were then advanced over 
a 0.035-inch Amplatz Superstiff guidewire (Med- 
itech) to the selected position , and balloon was de- 
ployed under fluoroscopic control. The proximal end 
of the PTFE-EG was secured first, followed by sepa- 
rate deployment of the distal stent with a 10 mm × 2 
cm Blue Max balloon catheter (Meditech). In the 
dogs treated with the TD-EGs, two devices were 
deployed sequentially precisely overlapping each 
other to decrease the porosity of the device. After 
graft deployment, arteriographic and IVUS assess- 
ment of the endovascular graft was performed to 
assure accurate and complete deployment. All cathe- 
ters and introducers ware removed, and the carotid 
artery was ligated with a 2-0 silk suture (Ethicon). 
The incision was closed with 4-0 polyglycolic add 
subcuticular sutures (Ethicon). 
Assessment of  endovascular exclusion 
After deployment of the endovascular device, de- 
terminations of IAP were made once a day using the 
silicon strain-gauge pressure transducer. A forelimb 
sphygmomanometer was used to measure systemic 
arterial pressure (SP) during IAP determinations. 
Percent IAP reduction was calculated by using the 
following formula: 
% IAP reduction = ([SP - IAP]/SP) × 100 
Dynamic computed tomographic (CT) scanning 
with intravenous contrast and color flow Duplex 
assessment of the endovascular graft were per- 
formed with the dog under general anesthesia 
(penrobarbital, 18 to 20 mg/kg)  during the fol- 
low-up period. The dogs were killed 18 to 50 days 
after the aneurysm exclusion procedure (mean, 
37.5 days). Microscopic and gross pathologic as- 
sessments of the endovascular graft and excluded 
artificial aneurysm were performed. The specimens 
were perfusion-fixed (pressure, 100 mm Hg) with glu- 
taraldehyde buffered to a pH of 7.4 with sodium 
cacodylate. The specimens were then embedded in 
paraffin, and trichrome and hematoxylin and eosin 
slides were prepared. 
Statistical analysis 
Comparisons of treatment groups were per- 
formed using Student's two-tailed t test. Statistical 
significance was assumed at the 95% confidence in- 
terval (p < 0.05). 
RESULTS 
Grafting and exclusion 
Endovascular device placement was successful in 
all dogs. Angiograms obtained at the time of the 
endovascular g afting procedure demonstrated com- 
plete exclusion of the aneurysm in all cases (Fig. 3). 
Patency of the renal and proximal lumbar arteries was 
assured, as was outflow into the distal aorta, trifurca- 
tion, and caudal mesenteric artery. Color flow duplex 
examination and dynamic CT scanning (Fig. 4) with 
intravenous contrast performed uring the follow-up 
period showed no perfusion of the aneurysmal sac in 
all cases, confirming aneurysmal exclusion. 
IAP data 
Mean IAP. The mean IAP after standard surgi- 
cal repair on the control dog was i2 mm Hg imme- 
diately after operation and stayed stable thereafter. 
The mean IAP after exclusion with the low-porosity 
PTFE-EG was significantly lower (p < 0.001) than 
the mean systemic pressures measured using a fore- 
limb sphygmomanometer. In addition, the mean 
IAP after deploying the low-porosity PTFE-EG was 
significantly ower than that after deploying the high- 
porosity TD-EG (p < 0.005; Fig. 5). The mean IAP 
after high-porosity TD-EG was not significantly 
lower than the systemic pressures obtained with the 
forelimb sphygmomanometer. 
The mean percent IAP reduction after low-po- 
rosity PTFE-EG was significantly greater than that 
after high-porosity TD-EG (62.0% + 13.1% vs 13% 
+- 9.5%; p < 0.005). The mean percent IAP reduc- 
tion after standard surgical repair was 88%. 
Intraaneurysmal pulse pressure measure- 
ments. The mean intraaneurysmal pulse pressure af- 
ter exclusion with the low-porosity PTFE-EG imme- 
diately decreased and stayed stable at a low state, 
whereas the placement of the high-porosity TD-EG 
did not significantly decrease the pulse pressure (Fig. 
6). The difference in the mean pulse pressure be- 
tween the two grafts were statistically significant (p < 
0.001). 
Pathologic findings 
Endovascular device implantation. On gross 
inspection, both graft types appeared to bc well in- 
corporated into the native aorta at the proximal and 
distal implantation sites (Fig. 7). Histologic analysis 
revealed thin accumulations of smooth muscle cells 
and extracellular matrix within the metallic struts of 
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Fig. 3. A, Arteriogram shows patent infrarenal prosthetic aneurysm. B, Arteriogram shows 
complete xclusion of aneurysm by PTFE endovascular g aft (arrow). 
Fig. 4. A, Duplex scan shows flow within endovascular g aft (G) and no flow within prosthetic 
aneurysm (PA). B, CT scan corroborates complete exclusion of aneurysm (black arrow) with 
flow only within stented endovascular g aft (SG). Curved arrow points to pressure transducer. 
each device. A layer of endothelial cells was consis- 
tently observed overlying the stents at the stent graft 
attachment site. However, in both grafts the midpor- 
tion of the graft was not endothelialized and was 
covered with a thin layer of fibrin. 
Intraaneurysmal  thrombus.  Gross pathologic 
examination of the aneurysms treated with the 
PTFE-EG demonstrated thrombus throughout he 
aneurysmal sac. Varying degrees of organization 
were present, with the outermost layers containing 
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Fig. 6. Chronic intraaneurysmal pulse pressure measurements. Mean intraancurysmal pulse 
pressure after exclusion with low-porosity PTFE-EG was significantly lower compared with that 
after high-porosity TD-EG. *p < 0.00i. 
pale, fibrinous, well-organized material. The inner 
layers close to the endovascular device were darker 
and more gelatinous, reflecting more recent deposi- 
tion. Microscopic evaluation confirmed the variation 
in thrombus organization, with the outer layers dem- 
onstrating fibrin deposition and laminations while 
the inner layers had less fibrin. In contrast to the 
low-porosity PTFE-EG, thrombus within the aneu- 
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Fig. 7. Photograph of explanted aneurysm treated with high-porosity TD-EG. Graft is well 
healed at arterial interfaces (A), and dark, rubbery thrombus (TH) appears relatively fresh. 
rysms treated with the high-porosity TD-EG ap- 
peared to be minimally organized. The coagulum 
was dark, rubbery, and gelatinous suggestive of  
continuous blood leakage (Fig. 7). On histologic 
examination, poorly defined strands of  fibrin were 
present. 
DISCUSSION 
A variety of devices are currently being evaluated 
and used clinically for the endovascular exclusion of 
AAAs. Stented graft devices use a vascular conduit 
such as Dacron or PTFE and expandable vascular 
stents to secure the conduit o the undilated arterial 
wall proximally and distally to the aneurysmal seg- 
ment. 9-~s Some stented grafts use fixation pins to 
enhance stent attachment to the arterial wall} 6 En- 
dovascular devices that use alloyed metals in combi- 
nation with synthetic fabric throughout the length of 
the device are also being evaluated and used} 1,~7-~8 A 
variety of complications have been reported after 
endovascular t eatment of  AAAs. Persistent perfu- 
sion of  the aneurysm sac as a result of ineffective 
device deployment has led to aneurysm rupture and 
death. 19 In addition, aneurysm expansion and rup- 
ture after technically successful endovascular graft 
deployment have been reported. 2° It is likely that 
these complications resulted from inadequate reduc- 
tion of IAP. Persistent patency of the arterial side 
branches of aneurysms has also been observed after 
technically successful deployment. 17 In addition, 
perianastomotic reflux is and perigraft channels ~° 
with arterial flow have been noted in aneurysms after 
endovascular exclusion. The effects that patent side 
branches, perianastomotic reflux, and perigraft chan- 
nels have on LAP are unclear and warrant further 
investigation. 
Because the efficacy of endovascular devices in 
lowering pressure within the aneurysm sac is essential 
for successful aneurysm treatment and because stud- 
ies have not been undertaken to chronically measure 
IAP after endovascular device deployment, we devel- 
oped an animal model that enables us to reliably 
determine pressures within an aortic aneurysm be- 
fore and after endovascular treatment. 8 We have used 
this model to assess the long-term effects of two 
endovascular devices. 
The PTFE endovascular graft, comprised of a 
low-porosity PTFE graft and two balloon-expand- 
able stents, is similar to endovascular grafts used 
successfully by Parodi et al.,9,13 Matin et al., 1° and 
others for the treatment ofaortoiliac aneurysms. This 
study clearly shows that the IAP is significantly de- 
creased within the aneurysm sac after repair using 
this device, and it approaches the low IAPs noted 
after standard repair. This study clearly shows that 
the LAP along with the pulse pressure is significantly 
decreased within the aneurysm sac after repair using 
this device. However, some residual pressure within 
the aneurysm was observed after endovascular exclu- 
sion. Although the current study supports the use of 
endovascular g afts for the exclusion of arterial aneu- 
rysms, the significance of the residual pressure on 
aneurysmal expansion is unclear, and therefore these 
patients need to be carefully observed. In our model, 
healing was noted at the interface between the stent 
and the proximal and distal aorta. Healing at this 
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interface in human aortas would be helpful for long- 
term stability of the aneurysm repair, but the limited 
data about endovascular graft healing in patients 
treated for aortic aneurysms uggest hat minimal 
healing occurs at these severely calcified vessels, and 
continued apposition of the device to the aortic wall 
depends on the characteristics of the attachment sys- 
tem used. 16 
Tantalum-Dacron grafts have been evaluated for 
the treatment of aortic aneurysms in an animal mod- 
el. :s The study showed that this highly porous endo- 
vascular graft was covered with a neointimal ayer 
after 6 weeks of implantation and it appeared to 
effectively treat the prosthetic artificial aneurysms, i  
It  has the advantage of a small profile and a simple 
delivery system. In our study, we confirmed that 
these grafts can be placed accurately across a pros- 
thetic aneurysm and that they appear to heal very 
well in the perianastomofic area. In addition, all 
available methods used for endovascular graft evalu- 
ation, which included angiography, IVUS, duplex 
scan, and dynamic CT scan, showed good apposition 
of the graft to the arterial wall and no signs of 
perigraft leaks or channels. Despite the results of 
these studies, the IAPs after repair with the tantalum- 
Dacron graft were not significantly different han the 
systemic pressures. These findings suggest hat a po- 
rous endovascular graft can promote aneurysm 
thrombosis and can be partially endothclialized in an 
animal model. However, arterial pressure is still 
transmitted to the aneurysm wall, rendering this type 
of aneurysm exclusion useless. 
Angiography, duplex scanning, and dynamic CT 
scanning are commonly used for the postoperative 
evaluation of patients treated with endovascular 
grafts to assess the repair for appropriate placement 
and perigraft or endograft leaks. In our study, ele- 
vated IAPs were noted in all aneurysms treated with 
the tantalum-Dacron e dovascular g aft, despite im- 
aging studies that suggested precise deployment and 
complete xclusion. The pressure transmitted to the 
aneurysm wall did not diminish despite the presence 
of thrombus occluding the graft interstices and a 
neointimal layer. These findings bring into question 
the importance of  small and large perigraft leaks that 
are noted after endovascular repair that "seal sponta- 
neously." Our findings may help explain why some 
aneurysms have been noted to enlarge or even rup- 
ture when an endovascular graft appears to totally 
exclude an aneurysm. In addition, the development 
of new diagnostic tests may be needed to better 
evaluate and observe patients after endovascular n- 
eurysm repairs. 
CONCLUSION 
Although standard surgical repair of  AAAs has 
proven to be clinically effective in preventing rupture, 
it can be associated with significant perioperative 
morbidity and mortality rates, particularly in patients 
with comorbid illnesses. Recently developed tech- 
niques for the endovascular t eatment of AAAs may 
reduce the morbidity and mortality rates ofaneurysm 
repair. However, the effectiveness of these tech- 
niques must be rigorously evaluated. Our model may 
be used to reliably evaluate the ability of current and 
future endovascular devices and delivery systems to 
reduce IAP after deployment. Insight into existing 
questions, such as the importance of perigraft chan- 
nels, efficacy of  different ypes of endovascular g afts, 
and future questions associated with endovascular 
graft repairs, can be obtained from future studies 
using this model. 
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